Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells
- PMID: 20556588
- DOI: 10.1007/s11596-010-0363-2
Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells
Abstract
The effects of combined RNA interference (RNAi) of human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) genes on telomerase activity in a bladder cancer cell line (BIU-87 cells) were investigated by using gene chip technology in vitro with an attempt to evaluate the role of RNAi in the gene therapy of bladder transitional cell cancer (BTCC). Three TR-specific double-stranded small interfering RNAs (siRNAs) and three TERT-specific double-stranded siRNAs were designed to target different regions of TR and TERT mRNA. The phTR-siRNA, phTERT-siRNA, and the combination of both plasmids phTR+phTERT-siRNA were transfected into BIU-87 cells. The expression of hTR and hTERT mRNA was detected by quantitative fluorescent reverse transcription-polymerase chain reaction, and a telomeric repeat amplification protocol was applied to detect telomerase activity. Growth inhibition of BIU-87 cells was measured by MTT assay. Gene chip analysis was performed to evaluate the effects of the combined RNAi of hTR+hTERT genes on telomerase activity and growth of BIU-87 cells in vitro. The results showed that the expression of hTERT and hTR mRNA was inhibited by pRNAT-hTERT-III, pRNAT-hTR-III, and pRNAT-hTR-III+hTERT-III in BIU-87 cells. The inhibition efficiency of pRNAT-hTERT-III, pRNAT-hTR-III, pRNAT-hTERT-III+pRNAT-hTR-III was 67% for TERT mRNA, 41% for TR mRNA, 57% for TR mRNA and 70% for TERT mRNA in BIU-87 cells respectively. The growth of BIU-87 cells was inhibited and telomerase activity was considerably decreased, especially in the cells treated with combined RNAi-hTR and -hTERT. Gene chip analysis revealed that 21 genes were down-regulated (ATM, BAX, BCL2, BCL2L1, BIRC5, CD44, CTNNB1, E2F1, JUN, MCAM, MTA1, MYC, NFKB1, NFKBIA, NME4, PNN, PNN, SERPINE1, THBS1, TNFRSF1A, and UCC1). The results indicated that hTR-siRNA and hTERT-siRNA, especially their combination, siRNA hTR+hTERT, specifically and effectively suppressed the expression of both hTR and hTERT mRNA and telomerase activity. Molecular biological mechanism by which combined siRNA-TR and -TERT inhibited telomerase activity and growth of BIU-87 cells in vitro may involve the down-regulation of the 21 genes.
Similar articles
-
[Effects of combining siRNA-TR and TERT upon telomerase activity and in vitro growth inhibition in transitional cancer of bladder BIU-87 cell line].Zhonghua Yi Xue Za Zhi. 2009 Nov 3;89(40):2847-52. Zhonghua Yi Xue Za Zhi. 2009. PMID: 20137667 Chinese.
-
Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.Int J Urol. 2006 Apr;13(4):401-8. doi: 10.1111/j.1442-2042.2006.01300.x. Int J Urol. 2006. PMID: 16734859
-
Inhibition of proliferation and induction of apoptosis in human renal carcinoma cells by anti-telomerase small interfering RNAs.Acta Biochim Biophys Sin (Shanghai). 2006 Jul;38(7):500-6. doi: 10.1111/j.1745-7270.2006.00182.x. Acta Biochim Biophys Sin (Shanghai). 2006. PMID: 16820866
-
Expression of telomerase genes in thyroid carcinoma.Int J Oncol. 2002 Aug;21(2):265-72. Int J Oncol. 2002. PMID: 12118320 Review.
-
hTERT, hTR and TERT promoter mutations as markers for urological cancers detection: A systematic review.Urol Oncol. 2021 Aug;39(8):498.e21-498.e33. doi: 10.1016/j.urolonc.2021.01.022. Epub 2021 Mar 3. Urol Oncol. 2021. PMID: 33676848
Cited by
-
Targeting Human Telomerase Reverse Transcriptase by a Simple siRNA Expression Cassette in HepG2 Cells.Hepat Mon. 2015 Mar 31;15(3):e24343. doi: 10.5812/hepatmon.24343. eCollection 2015 Mar. Hepat Mon. 2015. PMID: 25861317 Free PMC article.
-
Regulation of telomerase towards tumor therapy.Cell Biosci. 2023 Dec 18;13(1):228. doi: 10.1186/s13578-023-01181-6. Cell Biosci. 2023. PMID: 38111043 Free PMC article. Review.
-
Telomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various Diseases.Cells. 2019 Apr 28;8(5):392. doi: 10.3390/cells8050392. Cells. 2019. PMID: 31035374 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous